Product Images Arformoterol Tartrate

Arformoterol Tartrate Inhalation Solution is a medication that comes in a pre-measured dose of 15 micrograms per 2 milliliters. It is packaged in a pouched form and can be stored at room temperature for up to 2 weeks before expiring. The medication should not be used after the expiration date or discarded improperly. The drug is intended for inhalation use only and should not be administered in any other way.*

Arformoterol Tartrate Inhalation Solution is a prescription drug that is available in a 15 meg/2 mL dosage, and the potency expressed is as arformoterol. It should be stored in a refrigerator or at room temperature for up to two weeks. This medication is for oral use only and is meant for patients with breathing complications. The text also includes the National Drug Code and dosage information for the prescription.*

Arformoterol Tartrate is an inhalation solution. Each single unit dose vial contains 15 mig of aromoterol, which is equivalent to 0.2 mg of arformoterol tartrate in a sterile, isotonic saline solution with 1.5% w/v of benzalkonium chloride and sodium chloride. After opening the pouch, the unused vials should be kept out of the reach of children and those exposed to excessive heat. Unopened pouched unit dose vials can be stored in a refrigerator (2°C to 8°C, 36°F to 46°F). It's recommended to use only as directed by a physician and do not exceed the recommended dosage. The manufacturer is Nombic Pharmaceuticals.*

This is a product description for a face mask. There are two figures included, but it is not possible to determine what they illustrate without further context.*

This appears to be a graph showing changes in FEV1 (a measure of lung function) over time (up to 12 hours post-dose) in two groups of patients: one group receiving a placebo and another group receiving 15 micrograms of arformoterol tartrate inhalation solution twice daily. The baseline FEV1 measurements for the two groups were 120 and 1.15 liters, respectively.*

This appears to be a graph showing the change from baseline forced expiratory volume (FEV) over time for a placebo group and a group receiving a 15 meg Arformoterol tartrate inhalation solution twice daily. The x-axis represents hours postdose and the y-axis represents the change in FEV from baseline.*